. GSK to CoDevelop merckgroups Cancer Immunotherapy Candidate M7824 in $4.2B Alliance httpow.ly9dpz30nALnUÂ

. @GSK to Co-Develop @merckgroup’s #Cancer #Immunotherapy Candidate M7824 in $4.2B Alliance: http://ow.ly/9dpz30nALnU 

17:25 EST 5 Feb 2019 | Genetic Engineering News

. @GSK to Co-Develop @merckgroup’s #Cancer #Immunotherapy Candidate M7824 in $4.2B Alliance: http://ow.ly/9dpz30nALnU 

More From BioPortfolio on ". @GSK to Co-Develop @merckgroup’s #Cancer #Immunotherapy Candidate M7824 in $4.2B Alliance: http://ow.ly/9dpz30nALnU "